PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population (Q44510088)

3 December 2017

title

PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population (English)

1 reference

3 December 2017

0 references

1 reference

4

1 reference

3 December 2017

C Lopes

1

1 reference

3 December 2017

C Dina

series ordinal

2

1 reference

3 December 2017

E Durand

series ordinal

3

1 reference

3 December 2017

publication date

11 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

46

1 reference

3 December 2017

issue

9

1 reference

3 December 2017

page(s)

1284-1290

1 reference

Factors of insulin resistance syndrome--related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic mexican-americans

3 December 2017

cites work

1 reference

12 December 2020

Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis

1 reference

12 December 2020

The adipocyte and hemostatic balance in obesity: studies of PAI-1.

1 reference

12 December 2020

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

1 reference

12 December 2020

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Diabetic Retinopathy, Promoter (4G/5G) Polymorphism of PAI-1 Gene, and PAI-1 Activity in Pima Indians With Type 2 Diabetes

1 reference

12 December 2020

Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family

1 reference

12 December 2020

The common -675 4G/5G polymorphism in the plasminogen activator inhibitor -1 gene is strongly associated with obesity.

1 reference

12 December 2020

Big Dye terminator cycle sequencing chemistry: accuracy of the dilution process and application for screening mutations in the TCF1 and GCK genes

1 reference

12 December 2020

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

1 reference

12 December 2020

Elite swimmers and the D allele of the ACE I/D polymorphism

1 reference

12 December 2020

A simple method for displaying the hydropathic character of a protein

1 reference

12 December 2020

PAI-1, obesity, insulin resistance and risk of cardiovascular events

1 reference

12 December 2020

Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease

1 reference

12 December 2020

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

1 reference

12 December 2020

Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin

1 reference

12 December 2020

Genetic associations with human longevity at the APOE and ACE loci

1 reference

12 December 2020

Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein

1 reference

12 December 2020

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

1 reference

12 December 2020

Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes.

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Five Frequent Polymorphisms of the PAI-1 Gene

1 reference

12 December 2020

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

1 reference

12 December 2020

Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis

1 reference

12 December 2020

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1 reference

12 December 2020

The angiotensin converting enzyme I/D polymorphism in Russian athletes

1 reference

12 December 2020

Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction

1 reference

12 December 2020

An algorithm for protein secondary structure prediction based on class prediction.

1 reference

12 December 2020

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

1 reference

12 December 2020

Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland

1 reference

12 December 2020

Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice.

1 reference

12 December 2020

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

1 reference

12 December 2020

Identification of N-acetyltransferase 2 genotypes by continuous monitoring of fluorogenic hybridization probes

1 reference

12 December 2020

Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

1 reference

12 December 2020

Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.

1 reference

12 December 2020

To: J. Hoffstedt et al. (2002) The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity

1 reference

12 December 2020

Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis

1 reference

12 December 2020

Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma

1 reference

12 December 2020

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

12 December 2020

A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans

1 reference

12 December 2020

10.1007/S00125-003-1170-0

Identifiers

DOI

1 reference

release_tq73wdcqtbdbfkciwtqvu23mxu

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tq73wdcqtbdbfkciwtqvu23mxu

24 November 2022

mapped directly with Wikidata item

1 reference